Index Entries

Zafran Khan, Ubaid Ahmad, Daniya Ualiyeva, Obed Boadi Amissah, Asaf Khan, Zohaib Noor, and Nasib Zaman
December 23, 2021
Clinical Immunology Communications
University of Swat (Pakistan)

"Abstract

Recent evidence has shown that some COVID-19-vaccinated individuals can occasionally develop as a potential side effect Guillain-Barre syndrome (GBS), a severe neurological autoimmune condition in which the immune response against the peripheral nerve system (PNS) can result in significant morbidity. GBS had been linked previously to several viral or bacterial infections, and the finding of GBS after vaccination with certain COVID-19, while rare, should alert medical practitioners for an early diagnosis and targeted treatment. Here we review five cases of GBS that developed in different countries after COVID-19 vaccination...

3.1. Correlation between COVID-19 vaccine and GBS

The correlation between GBS and COVID-19 vaccine is presented by many cases reported in several countries across the world."

document
adverse events,autoimmunity,COVID-19,neurological disorders,vaccines